United States · Bill · HR
H.R. 27 (119th)
HALT Fentanyl Act
Introduced
3 January 2025
Last action
10 February 2025 · Introduced
Status
Received in the Senate and Read twice and referred to the Committee on the Judiciary.
Sponsors
Rep. Griffith, H. Morgan [R-VA-9], Rep. Latta, Robert E. [R-OH-5], Rep. Guthrie, Brett [R-KY-2], Rep. Bilirakis, Gus M. [R-FL-12], Rep. Hudson, Richard [R-NC-8], Rep. Carter, Earl L. "Buddy" [R-GA-1], Rep. Palmer, Gary J. [R-AL-6], Rep. Dunn, Neal P. [R-FL-2], Rep. Crenshaw, Dan [R-TX-2], Rep. Joyce, John [R-PA-13], Rep. Pfluger, August [R-TX-11], Rep. Harshbarger, Diana [R-TN-1], Rep. Cammack, Kat [R-FL-3], Rep. Miller-Meeks, Mariannette [R-IA-1], Rep. Womack, Steve [R-AR-3], Rep. Buchanan, Vern [R-FL-16], Rep. Miller, Carol D. [R-WV-1], Rep. Moolenaar, John R. [R-MI-2], Rep. Bost, Mike [R-IL-12], Rep. Evans, Gabe [R-CO-8], Rep. Fitzgerald, Scott [R-WI-5], Rep. Langworthy, Nicholas A. [R-NY-23], Rep. Cline, Ben [R-VA-6], Rep. Meuser, Daniel [R-PA-9], Rep. Van Drew, Jefferson [R-NJ-2], Rep. Feenstra, Randy [R-IA-4], Rep. Nunn, Zachary [R-IA-3], Rep. Ciscomani, Juan [R-AZ-6], Rep. Stauber, Pete [R-MN-8], Rep. Wagner, Ann [R-MO-2], Rep. Balderson, Troy [R-OH-12], Rep. Higgins, Clay [R-LA-3], Rep. Ellzey, Jake [R-TX-6], Rep. Fleischmann, Charles J. "Chuck" [R-TN-3], Rep. Fry, Russell [R-SC-7], Rep. Houchin, Erin [R-IN-9], Rep. Rogers, Harold [R-KY-5], Rep. Obernolte, Jay [R-CA-23], Rep. Webster, Daniel [R-FL-11], Rep. Burchett, Tim [R-TN-2], Rep. Scott, Austin [R-GA-8], Rep. Walberg, Tim [R-MI-5], Rep. Fischbach, Michelle [R-MN-7], Rep. Wittman, Robert J. [R-VA-1], Rep. Murphy, Gregory F. [R-NC-3], Rep. Franklin, Scott [R-FL-18], Rep. Baumgartner, Michael [R-WA-5], Rep. Ryan, Patrick [D-NY-18]
Subjects
Discovery layer
Source updated
10 August 2026
Summary
Halt All Lethal Trafficking of Fentanyl Act or the HALT Fentanyl Act This bill permanently places fentanyl-related substances as a class into schedule I of the Controlled Substances Act. A schedule I controlled substance is a drug, substance, or chemical that has a high potential for abuse; has no currently accepted medical value; and is subject to regulatory controls and administrative, civil, and criminal penalties under the Controlled Substances Act. Under the bill, offenses involving fentanyl-related substances are triggered by the same quantity thresholds and subject to the same penalties as offenses involving fentanyl analogues (e.g., offenses involving 100 grams or more trigger a 10-year mandatory minimum prison term). Additionally, the bill establishes a new, alternative registration process for certain schedule I research. The bill also makes several other changes to registration requirements for conducting research with controlled substances, including permitting a single registration for related research sites in certain circumstances, waiving the requirement for a new inspection in certain situations, and allowing a registered researcher to perform certain manufacturing activities with small quantities of a substance without obtaining a manufacturing registration. Finally, the bill expresses the sense that Congress agrees with the interpretation of Controlled Substances Act in United States v. McCray , a 2018 case decided by the U.S. District Court for the Western District of New York. In that case, the court held that butyryl fentanyl, a controlled substance, can be considered an analogue of fentanyl even though, under the Controlled Substances Act, the term controlled substance analogue specifically excludes a controlled substance.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
3 January 2025
Introduced
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Source: IntroReferral
3 January 2025
Introduced
Introduced in House
Source: IntroReferral
3 January 2025
Introduced
Introduced in House
Source: IntroReferral
4 February 2025
Reported
Rules Committee Resolution H. Res. 93 Reported to House. Rule provides for consideration of H.R. 27 with 1 hour of general debate. Motion to recommit allowed. The resolution makes in order only the further amendment printed in Part B of the Rules Committee report.
Source: Floor
5 February 2025
Passed
Rule H. Res. 93 passed House.
Source: Floor
6 February 2025
Passed
Motion to reconsider laid on the table Agreed to without objection.
Source: Floor
6 February 2025
Vote
On passage Passed by the Yeas and Nays: 312 - 108 (Roll no. 33). (text: CR H520-522)
Source: Floor
6 February 2025
Vote
Passed/agreed to in House: On passage Passed by the Yeas and Nays: 312 - 108 (Roll no. 33). (text: CR H520-522)
Source: Floor
6 February 2025
Floor
Considered under the provisions of rule H. Res. 93. (consideration: CR H520-533)
Source: Floor
6 February 2025
Floor
Rule provides for consideration of H.R. 27 with 1 hour of general debate. Motion to recommit allowed. The resolution makes in order only the further amendment printed in Part B of the Rules Committee report.
Source: Floor
10 February 2025
Introduced
Received in the Senate and Read twice and referred to the Committee on the Judiciary.
Source: IntroReferral
Votes
6 February 2025 · passed · On Passage · Passed · Official source
Yes 312 · No 108 · Abstain — · Absent/not voting 13
- Rep. Bean, Aaron [R-FL-4]Yea
- Rep. Hamadeh, Abraham J. [R-AZ-8]Yea
- Rep. Gray, Adam [D-CA-13]Yea
- Rep. Smith, Adam [D-WA-9]Nay
Showing the first 4 recorded positions. Vote totals above are complete.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
4 official files
Referred in Senate
This file cannot be previewed here. Use View or Download.
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Referred in Senate
Referred in Senate · EN · 10 February 2025
Engrossed in House
Engrossed in House · EN · 6 February 2025
ViewDownloadOpen at official source
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Introduced in House
Introduced in House · EN · 3 January 2025
ViewDownloadOpen at official source
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Introduced in House
summary · EN · 3 January 2025
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Sponsors
- Rep. Griffith, H. Morgan [R-VA-9] · R · Sponsor
- Rep. Latta, Robert E. [R-OH-5] · R · Sponsor
- Rep. Guthrie, Brett [R-KY-2] · R · Sponsor
- Rep. Bilirakis, Gus M. [R-FL-12] · R · Sponsor
- Rep. Hudson, Richard [R-NC-8] · R · Sponsor
- Rep. Carter, Earl L. "Buddy" [R-GA-1] · R · Sponsor
- Rep. Palmer, Gary J. [R-AL-6] · R · Sponsor
- Rep. Dunn, Neal P. [R-FL-2] · R · Sponsor
- Rep. Crenshaw, Dan [R-TX-2] · R · Sponsor
- Rep. Joyce, John [R-PA-13] · R · Sponsor
- Rep. Pfluger, August [R-TX-11] · R · Sponsor
- Rep. Harshbarger, Diana [R-TN-1] · R · Sponsor
- Rep. Cammack, Kat [R-FL-3] · R · Sponsor
- Rep. Miller-Meeks, Mariannette [R-IA-1] · R · Sponsor
- Rep. Womack, Steve [R-AR-3] · R · Sponsor
- Rep. Buchanan, Vern [R-FL-16] · R · Sponsor
- Rep. Miller, Carol D. [R-WV-1] · R · Sponsor
- Rep. Moolenaar, John R. [R-MI-2] · R · Sponsor
- Rep. Bost, Mike [R-IL-12] · R · Sponsor
- Rep. Evans, Gabe [R-CO-8] · R · Sponsor
- Rep. Fitzgerald, Scott [R-WI-5] · R · Sponsor
- Rep. Langworthy, Nicholas A. [R-NY-23] · R · Sponsor
- Rep. Cline, Ben [R-VA-6] · R · Sponsor
- Rep. Meuser, Daniel [R-PA-9] · R · Sponsor
- Rep. Van Drew, Jefferson [R-NJ-2] · R · Sponsor
- Rep. Feenstra, Randy [R-IA-4] · R · Sponsor
- Rep. Nunn, Zachary [R-IA-3] · R · Sponsor
- Rep. Ciscomani, Juan [R-AZ-6] · R · Cosponsor
- Rep. Stauber, Pete [R-MN-8] · R · Cosponsor
- Rep. Wagner, Ann [R-MO-2] · R · Cosponsor
- Rep. Balderson, Troy [R-OH-12] · R · Cosponsor
- Rep. Higgins, Clay [R-LA-3] · R · Cosponsor
- Rep. Ellzey, Jake [R-TX-6] · R · Cosponsor
- Rep. Fleischmann, Charles J. "Chuck" [R-TN-3] · R · Cosponsor
- Rep. Fry, Russell [R-SC-7] · R · Cosponsor
- Rep. Houchin, Erin [R-IN-9] · R · Cosponsor
- Rep. Rogers, Harold [R-KY-5] · R · Cosponsor
- Rep. Obernolte, Jay [R-CA-23] · R · Cosponsor
- Rep. Webster, Daniel [R-FL-11] · R · Cosponsor
- Rep. Burchett, Tim [R-TN-2] · R · Cosponsor
- Rep. Scott, Austin [R-GA-8] · R · Cosponsor
- Rep. Walberg, Tim [R-MI-5] · R · Cosponsor
- Rep. Fischbach, Michelle [R-MN-7] · R · Cosponsor
- Rep. Wittman, Robert J. [R-VA-1] · R · Cosponsor
- Rep. Murphy, Gregory F. [R-NC-3] · R · Cosponsor
- Rep. Franklin, Scott [R-FL-18] · R · Cosponsor
- Rep. Baumgartner, Michael [R-WA-5] · R · Cosponsor
- Rep. Ryan, Patrick [D-NY-18] · D · Cosponsor
Showing 48 of 65 sponsors and actors.
Related records
- related to ← HALT Fentanyl Act
- related to ← Providing for consideration of the bill (H.R. 27) to amend the Controlled Substances Act with respect to the scheduling of fentanyl-related substances, and for other purposes.
- amends ← An amendment numbered 2 printed in Part B of House Report 119-2 to delay the enactment of this bill until the Secretary of Health and Human Services and the Attorney General each certify that the bill will lead to a reduction in overdose deaths.
- amends ← Pursuant to the provisions of H. Res. 93, the amendment printed in part A of House Report 119-2 is considered as adopted.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/119th-congress/house-bill/27
- Open data entity: https://api.congress.gov/v3/bill/119/hr/27
- us · 119-hr-27 · source updated 10 August 2026